US Bancorp DE Sells 711 Shares of STERIS plc (NYSE:STE)

US Bancorp DE decreased its holdings in shares of STERIS plc (NYSE:STEFree Report) by 2.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 25,023 shares of the medical equipment provider’s stock after selling 711 shares during the quarter. US Bancorp DE’s holdings in STERIS were worth $5,630,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. 1832 Asset Management L.P. bought a new position in STERIS in the first quarter worth approximately $25,000. Harbor Capital Advisors Inc. bought a new position in STERIS in the second quarter worth approximately $26,000. Fiduciary Alliance LLC bought a new position in STERIS in the second quarter worth approximately $31,000. EverSource Wealth Advisors LLC grew its stake in STERIS by 144.3% in the first quarter. EverSource Wealth Advisors LLC now owns 171 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 101 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. bought a new position in STERIS in the second quarter worth approximately $44,000. Institutional investors own 92.91% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on STE. Stephens reissued an “overweight” rating and issued a $250.00 price objective on shares of STERIS in a research note on Monday, September 25th. KeyCorp upped their target price on STERIS from $254.00 to $258.00 and gave the stock an “overweight” rating in a report on Thursday, August 3rd. assumed coverage on STERIS in a report on Thursday, October 5th. They set a “buy” rating for the company. Piper Sandler lowered their target price on STERIS from $220.00 to $215.00 and set a “neutral” rating for the company in a report on Thursday, October 26th. Finally, JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, November 9th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $242.60.

Read Our Latest Research Report on STE

STERIS Stock Performance

Shares of STE opened at $199.80 on Tuesday. STERIS plc has a 12 month low of $166.99 and a 12 month high of $254.00. The stock has a fifty day moving average price of $217.18 and a 200-day moving average price of $217.50. The company has a current ratio of 2.49, a quick ratio of 1.55 and a debt-to-equity ratio of 0.54. The firm has a market cap of $19.74 billion, a PE ratio of 36.13 and a beta of 0.87.

STERIS (NYSE:STEGet Free Report) last issued its quarterly earnings data on Tuesday, November 7th. The medical equipment provider reported $2.03 EPS for the quarter, missing the consensus estimate of $2.05 by ($0.02). STERIS had a net margin of 10.52% and a return on equity of 13.58%. The business had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.30 billion. During the same quarter in the prior year, the company posted $1.99 EPS. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. Equities research analysts predict that STERIS plc will post 8.7 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 21st. Stockholders of record on Tuesday, November 21st will be issued a dividend of $0.52 per share. The ex-dividend date of this dividend is Monday, November 20th. This represents a $2.08 annualized dividend and a dividend yield of 1.04%. STERIS’s dividend payout ratio is presently 37.61%.

STERIS Company Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Articles

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with's FREE daily email newsletter.